HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,785 Cr | ₹2,023 Cr | ₹1,943 Cr | ₹1,720 Cr | ₹1,507 Cr |
What is the latest Revenue of HIKAL ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,785 Cr |
| Mar2024 | ₹2,023 Cr |
| Mar2023 | ₹1,943 Cr |
| Mar2022 | ₹1,720 Cr |
| Mar2021 | ₹1,507 Cr |
How is Revenue of HIKAL Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,785 Cr | -11.79 | |
| Mar2024 | ₹2,023 Cr | 4.13 | |
| Mar2023 | ₹1,943 Cr | 12.92 | |
| Mar2022 | ₹1,720 Cr | 14.14 | |
| Mar2021 | ₹1,507 Cr | - | |
Compare Revenue of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,478.9 Cr | -2% | -11.9% | -22% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| CIPLA | ₹114,163.0 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -2% |
-11.9% |
-22% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses